If you have been reading about AOD-9604 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2025-11-16. Numbers and descriptions here follow the published literature rather than marketing material.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
Qingzhou (Chinese: 轻舟货运飞船; pinyin: Qīngzhōu huòyùn fēichuán) is a class of cargo spacecraft developed by CAS Space, a company founded by the Chinese Academy of Sciences. It is part of the China Manned Space Program's low-cost cargo transportation system designed to support the Tiangong space station. A prototype version of the Qingzhou spacecraft was successfully launched as the primary payload of the maiden flight of the Kinetica-2 (Lijian-2) rocket on 30 March 2026. The first production-standard spacecraft is expected to be ready for flight by late 2026.
=== Brunei === The Royal Brunei Armed Forces uses a 24-hour ration pack that provides a soldier with an entire day's supply of food, plus a limited number of health and hygiene items. Maximum use is made of plastic-foil laminate pouches, and most items can be eaten without further preparation. Currently, four menus are fielded, and all menus are compatible with Muslim dietary restrictions. Example Menu (F): 5 x 170-gram retort pouches (Biriani Chicken, Beef Stir Fry, Sardines in Tomato Sauce, Bubur Jagong/ Corn Porridge, Pineapple Pajeri); plus individual servings of pineapple jam, instant coffee, teabags, sugar, salt, pepper, steminder powder, hot chili sauce, MSG, a multivitamin energy tablet, tissue paper, scouring pad with soap, and matches.
== Specific varieties == Tripolite is the variety found in Tripoli, Libya. Bann clay is the variety found in the Lower Bann valley in Northern Ireland. Moler (mo-clay) is the variety found in northwestern Denmark, especially on the islands of Fur and Mors. Freshwater-derived food grade diatomaceous earth is the type used in United States agriculture for grain storage, as feed supplement, and as an insecticide. It is produced uncalcinated, has a very fine particle size, and is very low in crystal silica (<2%). Salt-water-derived pool / beer / wine filter grade is not suitable for human consumption or effective as an insecticide. Usually calcinated before being sold to remove impurities and undesirable volatile contents, it is composed of larger particles than the freshwater version and has a high crystalline silica content (>60%).
Sources: en.wikipedia.org
=== Pain and pain management === Most patients report mild to moderate pain during insertion, and a minority report severe pain. Clinicians tend to underestimate this pain. In a study of 200 insertions, patients rated their peak pain at a mean of 65 on a 100-point scale, while providers rated it at 35. Guidelines historically did not recommend routine pain relief, and patients sharing their experiences on social media in the 2020s increased scrutiny of the practice. In 2025 the American College of Obstetricians and Gynecologists (ACOG) acknowledged that many patients feel clinicians have dismissed their pain. Options include NSAIDs, topical lidocaine, a paracervical block, nitrous oxide, inhaled methoxyflurane (the "green whistle"), and intravenous sedation or general anaesthesia where available. Sedation and general anaesthesia usually require a referral or separate appointment. Some clinics also offer virtual reality headsets for distraction. Evidence for individual methods is mixed. A Cochrane review found that lidocaine gel and most NSAIDs did not reduce pain, while some lidocaine formulations, tramadol and naproxen helped in some groups. A 2026 meta-analysis found no significant effect of virtual reality on pain. Paracervical block is underused in the United States. The US CDC and ACOG recommend that clinicians discuss expected pain and pain relief options with every patient before insertion.
In May 2010, In-N-Out announced plans to open new spots into Texas, specifically within the Dallas–Fort Worth area with the first In-N-Out opening in Frisco and Allen on May 11, 2011. The chain opened its first location in Austin in December 2013. There are 18 restaurant locations in the Dallas–Fort Worth area, and four in the Austin area. These new locations in Texas required the company to build a new patty production facility and distribution center in the state, according to company vice president Carl Van Fleet. In March 2014, the company confirmed its first location in San Antonio. The fall of 2014 saw the restaurant open its 22nd Texas location in Killeen. On November 20, 2014, In-N-Out opened its first location in San Antonio followed by its first location in Waco in November 2015. In January 2017, In-N-Out announced plans to expand into Houston with multiple sites planned in the area, the first being in Stafford. In January 2015, In-N-Out opened its 300th restaurant, which was located in Anaheim, California. At the time of the opening, the company had generated $558 million in annual sales and employed nearly 18,000 in California, Nevada, Utah, Texas, and Arizona. The company opened its first location in Oregon on September 9, 2015 (the same day as Harry Snyder's birthday) in Medford. It is supplied from the Lathrop, California, distribution center completed in 2006. President Lynsi Snyder stated during the opening that they will continue to open new spots. A second Oregon location was under construction in Grants Pass during September 2017.
== Career == Platt makes his decisions about accepting acting roles based on the role being "different from what I just did...I do have to be interested in the role". After Married to the Mob, he appeared in Working Girl (1988), Flatliners (1990), Beethoven (1992), The Three Musketeers (1993), A Time to Kill (1996), Executive Decision (1996), and Bulworth (1998). In 1998 Platt and Stanley Tucci played two deadbeat actors who improvise with unsuspecting strangers in The Impostors. Tucci and Platt developed the characters while working on a play at Yale University in 1988, with Tucci later completing the screenplay and directing the film. In 1999, Platt played the wealthy and eccentric crocodile enthusiast Hector in David E. Kelley's Lake Placid, alongside Bill Pullman and Bridget Fonda. Platt described Hector as "pretty abrasive and obnoxious at times, but, I hope, he has a way of growing on you. I think David originally thought of him as a great white hunter sort of guy, but when I signed on for the role he sort of wrote him in a different direction." The short-lived drama Deadline provided Platt's first lead role on television. Created by Dick Wolf, who also created Law & Order, Deadline focused on the lives of newspaper journalists in New York City. Platt starred as Pulitzer Prize-winning columnist Wallace Benton, an "unlikely hero". The strong cast, which also included Bebe Neuwirth and Hope Davis, could not compensate for substandard writing and the series was soon canceled.
=== Neonate === To ensure the safety of blood transfusion to pediatric patients, hospitals are taking additional precautions to avoid infection and prefer to use pediatric blood units that are guaranteed "safe" from Cytomegalovirus. Some guidelines have recommended the provision of CMV-negative blood components and not simply leukoreduced components for newborns or low birthweight infants in whom the immune system is not fully developed, but practice varies. These requirements place additional restrictions on blood donors who can donate for neonatal use, which may be impractical given the rarity of CMV seronegative donors and the preference for fresh units. Neonatal transfusions typically fall into one of two categories:
Sources: en.wikipedia.org
Davidson, Alan (1979). North Atlantic Seafood. ISBN 0-670-51524-8. Kurlansky, Mark (1997). Cod: A Biography of the Fish That Changed the World. New York: Walker. ISBN 0-8027-1326-2. Sanjuán, Gloria (2009). La Cocina del Bacalao. Madrid: Libro Hobby. ISBN 978-84-9736-242-9.
== Natural occurrence == Potassium alum dodecahydrate occurs in nature as a sulfate mineral called alum-(K), typically as encrustations on rocks in areas of weathering and oxidation of sulfide minerals and potassium-bearing minerals. In the past, potassium alum has been obtained from alunite (KAl(SO4)2·2Al(OH)3), mined from sulfur-containing volcanic sediments. Alunite is an associate and likely potassium and aluminium source. It has been reported at Vesuvius, Italy; east of Springsure, Queensland; in Alum Cave, Tennessee; Alum Gulch, Santa Cruz County, Arizona and the Philippine island of Cebu. In order to obtain alum from alunite, it is calcined and then exposed to the action of air for a considerable time. During this exposure it is kept continually moistened with water, so that it ultimately falls to a very fine powder. This powder is then lixiviated with hot water, the liquor decanted, and the alum allowed to crystallize. The undecahydrate also occurs as the fibrous mineral kalinite (KAl(SO4)2·12H2O).
=== First complete nucleotide sequence of a biological nucleic acid molecule === Although determining the sequence of proteins was becoming somewhat routine, methods for sequencing of nucleic acids were not available until the mid-1960s. In this seminal work, a specific tRNA was purified in substantial quantities, and then sliced into overlapping fragments using a variety of ribonucleases. Analysis of the detailed nucleotide composition of each fragment provided the information necessary to deduce the sequence of the tRNA. Today, the sequence analysis of much larger nucleic acid molecules is highly automated and much faster.
On April 6, 2019, Sanders participated in a Fox News town hall that attracted more than 2.55 million viewers. His decision to appear on Fox was controversial, given the Democratic National Committee's decision not to allow Fox to host any of its debates. His appearance saw an increase of Fox News viewers by 24% overall and 40% in the 25-to-54-year-old demographic, surpassing the ratings of all other Democratic presidential candidate town halls that year. As of September 2019, the town hall had more than 1.5 million views on YouTube. On August 6, 2019, Sanders appeared on The Joe Rogan Experience podcast. Some praised Rogan for "hosting a pragmatic discussion" while others "seemed rather stunned by Sanders's decision to appear on the show at all". After the podcast, Rogan became a top-trending Twitter topic. After interviewing him, Rogan said, "I am not right-wing ... I've interviewed right-wing people. I am 100% left-wing ... Bernie Sanders made a ton of sense to me and I would 100% vote for him." As of October 2019, the podcast had received more than ten million views on YouTube.
1% (w/w) Nonidet P-40 (NP-40) 1% (w/v) sodium deoxycholate 0.1% (w/v) SDS 0.15 M NaCl 0.01 M sodium phosphate, pH 7.2 2 mM EDTA 50 mM sodium fluoride (NaF) 0.2 mM fresh sodium orthovanadate (Na3VO4.2H2O, it has phosphatase inhibitor function because it mimics phosphate) 100 U/ml protease inhibitor, such as aprotinin
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
Lyophilized powder is commonly stored at −20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept refrigerated and used within a limited period.